Dosing Calculation for Semaglutide
You need to administer 1.2 mL of the semaglutide formulation to deliver a 3 mg dose.
Calculation
The calculation is straightforward using the concentration-dose formula:
- Available concentration: 2.5 mg/mL
- Desired dose: 3 mg
- Volume needed: 3 mg ÷ 2.5 mg/mL = 1.2 mL
Important Clinical Context
This 3 mg dose does not align with FDA-approved semaglutide dosing for any indication 1. The standard FDA-approved subcutaneous semaglutide formulations and dosing schedules are:
For Type 2 Diabetes (Ozempic):
- Starting dose: 0.25 mg once weekly
- Maintenance doses: 0.5 mg, 1 mg, or 2 mg once weekly 2
For Obesity/Weight Management (Wegovy):
- Starting dose: 0.25 mg once weekly
- Titrated monthly up to maximum dose: 2.4 mg once weekly 2
For Cardiovascular Risk Reduction:
- 2.4 mg once weekly 2
Critical Safety Considerations
A 3 mg weekly dose exceeds the maximum FDA-approved dose of 2.4 mg for obesity treatment and cardiovascular risk reduction. While higher doses (7.2 mg/week) are currently being investigated in phase III trials for obesity and T2DM 2, these are not yet approved for clinical use.
Before administering this dose, verify:
- The intended indication and whether this is part of an approved clinical trial protocol
- Whether this represents a compounded formulation with different dosing parameters
- That the prescriber intended 3 mg and not 0.3 mg (a potential decimal point error)
The standard commercial semaglutide pens deliver specific fixed doses and are not designed for custom dosing 1.